Found: 81
Select item for more details and to access through your institution.
The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 6849, doi. 10.1007/s00432-023-04628-y
- By:
- Publication type:
- Article
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 10, p. 2681, doi. 10.1007/s00432-020-03257-z
- By:
- Publication type:
- Article
Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08012-7
- By:
- Publication type:
- Article
Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1027890
- By:
- Publication type:
- Article
The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1015510
- By:
- Publication type:
- Article
Recent advances in Monoclonal antibodies based formulation used in the management of CRC.
- Published in:
- Journal of Pharmaceutical Negative Results, 2022, v. 13, p. 324, doi. 10.47750/pnr.2022.13.S06.047
- By:
- Publication type:
- Article
Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 11, p. 2620, doi. 10.3390/pharmaceutics15112620
- By:
- Publication type:
- Article
Preparation of a Zirconium-89 Labeled Clickable DOTA Complex and Its Antibody Conjugate.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 4, p. 480, doi. 10.3390/ph17040480
- By:
- Publication type:
- Article
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. e216, doi. 10.1016/j.clgc.2021.02.005
- Publication type:
- Article
A cautionary tale: an evaluation of the performance of treatment switching adjustment methods in a real world case study.
- Published in:
- BMC Medical Research Methodology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12874-024-02140-6
- By:
- Publication type:
- Article
Navigating metastatic colorectal treatment options in the USA: a survey of patient acceptance of skin toxicities associated with Vectibix.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 11, p. 6731, doi. 10.1007/s00520-021-06134-8
- By:
- Publication type:
- Article
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 7, p. 3971, doi. 10.1007/s00520-020-05972-2
- By:
- Publication type:
- Article
Panitumumab w leczeniu chorych na raka jelita grubego.
- Published in:
- Gastroenterologia Kliniczna, 2022, v. 14, n. 4, p. 139
- By:
- Publication type:
- Article
EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040499
- By:
- Publication type:
- Article
With metastatic colorectal cancer: A single center experience use of monoclonal antibodies (Bevacizumab, Cetuximab, and Panitumumab) in patients.
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2022, v. 39, n. 4, p. 1112, doi. 10.52142/omujecm.39.4.34
- By:
- Publication type:
- Article
Erosive pustular dermatosis of the scalp‐like eruption from panitumumab.
- Published in:
- Australasian Journal of Dermatology, 2022, v. 63, n. 2, p. 271, doi. 10.1111/ajd.13791
- By:
- Publication type:
- Article
Improvement of psoriasis in a patient with metastatic colon cancer after treatment with panitumumab.
- Published in:
- Australasian Journal of Dermatology, 2020, v. 61, n. 2, p. 171, doi. 10.1111/ajd.13203
- By:
- Publication type:
- Article
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21582-w
- By:
- Publication type:
- Article
Clinical outcomes of intermittent panitumumab based-therapy for previously treated older patient with metastatic colorectal cancer: a case report and review of literature.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1369952
- By:
- Publication type:
- Article
Editorial: Optimizing the first-line treatment for metastatic colorectal cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1366383
- By:
- Publication type:
- Article
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases--a phase II study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1231600
- By:
- Publication type:
- Article
Triplet‐drug chemotherapy combined with anti‐EGFR antibody as an effective therapy for patients with initially unresectable metastatic colorectal cancer: a meta-analysis.
- Published in:
- World Journal of Surgical Oncology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12957-023-03256-7
- By:
- Publication type:
- Article
A service evaluation at the Singleton Hospital (Swansea Bay University Health Board); Swansea, UK to examine capacity use (chair and treatment time) for metastatic colorectal cancer patients (mCRC) treated with EGFR therapies and chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, p. 89, doi. 10.1177/10781552231153542
- By:
- Publication type:
- Article
Panitumumab Associated Acute Pancreatitis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1207, doi. 10.1177/10781552221073997
- By:
- Publication type:
- Article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
- By:
- Publication type:
- Article
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1238, doi. 10.1007/s10147-021-01902-2
- By:
- Publication type:
- Article
Miller Fisher Syndrome and Cavernous Sinus Thrombosis Caused by Sinusitis.
- Published in:
- Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 424, doi. 10.14744/cpr.2023.43531
- By:
- Publication type:
- Article
Panitumumab Induced Paronychia and Trichomegaly.
- Published in:
- Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 422, doi. 10.14744/etd.2023.78646
- By:
- Publication type:
- Article
Erratum: Funding Acknowledgment.
- Published in:
- Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 426, doi. 10.14744/cpr.2023.21931
- Publication type:
- Article
PAPULO-PUSTULAR FOLLICULAR ERUPTION DURING PANITUMUMAB TREATMENT OF COLON CANCER.
- Published in:
- Dermatovenerologia Journal, 2021, v. 66, n. 4, p. 25
- By:
- Publication type:
- Article
Multidisciplinary management of locally recurrent rectal cancer with carbon ion radiotherapy followed by prophylactic removal of the irradiated bowel: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Curative resection after percutaneous drainage followed by preoperative panitumumab monotherapy for locally advanced sigmoid colon cancer with intra-abdominal abscess: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
PRIDE syndrome associated with panitumumab treatment - case report and literature review.
- Published in:
- Dermatology Review / Przeglad Dermatologiczny, 2023, v. 110, n. 1, p. 65, doi. 10.5114/dr.2023.127665
- By:
- Publication type:
- Article
Inference on tree‐structured subgroups with subgroup size and subgroup effect relationship in clinical trials.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 27, p. 5039, doi. 10.1002/sim.9900
- By:
- Publication type:
- Article
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00960-x
- By:
- Publication type:
- Article
Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1877, doi. 10.1007/s00262-021-03124-x
- By:
- Publication type:
- Article
An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 7108, doi. 10.3390/jcm11237108
- By:
- Publication type:
- Article
The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting—A Nation-Wide Retrospective Analysis (RACER).
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4361, doi. 10.3390/cancers15174361
- By:
- Publication type:
- Article
Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1715, doi. 10.3390/cancers12071715
- By:
- Publication type:
- Article
Error in Text Wording and Incorrect Reference.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 24, p. 2196, doi. 10.1001/jama.2023.10533
- Publication type:
- Article
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 15, p. 1271, doi. 10.1001/jama.2023.4428
- By:
- Publication type:
- Article
Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2021, v. 36, n. 12, p. 2621, doi. 10.1007/s00384-021-04002-9
- By:
- Publication type:
- Article
A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2020, v. 35, n. 12, p. 2197, doi. 10.1007/s00384-020-03693-w
- By:
- Publication type:
- Article
Efficacy and Safety of Systemic Treatments Among Colorectal Cancer Patients: A Network Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.756214
- By:
- Publication type:
- Article
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 5, p. 863, doi. 10.1002/ijc.34760
- By:
- Publication type:
- Article
Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 3, p. 488, doi. 10.1002/ijc.34733
- By:
- Publication type:
- Article
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 8, p. 1520, doi. 10.1002/ijc.34632
- By:
- Publication type:
- Article
Multicenter, single‐arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild‐type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell‐free DNA
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2172, doi. 10.1002/ijc.34184
- By:
- Publication type:
- Article
Early onset metastatic colorectal cancer in patients receiving panitumumab‐based upfront strategy: Overall and sex‐specific outcomes in the Valentino trial.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 10, p. 1760, doi. 10.1002/ijc.34156
- By:
- Publication type:
- Article
MYC Gene Mutations as Causative Pathways for Development and Treatment of Hematological Malignancies.
- Published in:
- Indian Journal of Forensic Medicine & Toxicology, 2022, v. 16, n. 1, p. 1689, doi. 10.37506/ijfmt.v16i1.17814
- By:
- Publication type:
- Article